Tryptophan Metabolism Is Associated with BMI and Adipose Tissue Mass and Linked to Metabolic Disease in Pediatric Obesity

Overview

Journal Nutrients

Date 2022 Jan 21

PMID 35057467

Authors

Julia Lischka

Andrea Schanzer

Margot Baumgartner

Charlotte de Gier

Susanne Greber-Platzer

Maximilian Zeyda

Affiliations

Soon will be listed here.

Abstract

The obesity epidemic has contributed to an escalating prevalence of metabolic diseases in children. Overnutrition leads to increased tryptophan uptake and availability. An association between the induction of the tryptophan catabolic pathway via indoleamine 2,3-dioxygenase (IDO) activity and obesity-related inflammation has been observed. This study aimed to investigate the impact of pediatric obesity on tryptophan metabolism and the potential relationship with metabolic disease. In this prospective cohort study, plasma kynurenine, tryptophan, and serotonin levels were measured by ELISA, and IDO activity was estimated by calculating the kynurenine/tryptophan ratio in a clinically characterized population with severe obesity (BMI ≥ 97th percentile) aged 9 to 19 ( = 125). IDO activity and its product kynurenine correlated with BMI z-score and body fat mass, whereas concentrations of serotonin, the alternative tryptophan metabolite, negatively correlated with these measures of adiposity. Kynurenine and tryptophan, but not serotonin levels, were associated with disturbed glucose metabolism. Tryptophan concentrations negatively correlated with adiponectin and were significantly higher in prediabetes and metabolically unhealthy obesity. In conclusion, BMI and body fat mass were associated with increased tryptophan catabolism via the kynurenine pathway and decreased serotonin production in children and adolescents with severe obesity. The resulting elevated kynurenine levels may contribute to metabolic disease in obesity.

Citing Articles

Endocrine and Metabolic Effects of Nutrition in Children and Adolescents.

Erhardt E, Molnar D Nutrients. 2025; 17(4).

PMID: 40005036 PMC: 11858772. DOI: 10.3390/nu17040707.

Tryptophan Metabolism in Obesity: The Indoleamine 2,3-Dioxygenase-1 Activity and Therapeutic Options.

Engin A, Engin A Adv Exp Med Biol. 2024; 1460:629-655.

PMID: 39287867 DOI: 10.1007/978-3-031-63657-8_21.

Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders.

Mor A, Tankiewicz-Kwedlo A, Ciwun M, Lewkowicz J, Pawlak D Cells. 2024; 13(15.

PMID: 39120289 PMC: 11311768. DOI: 10.3390/cells13151259.

Developmental Programming of the Fetal Immune System by Maternal Western-Style Diet: Mechanisms and Implications for Disease Pathways in the Offspring.

Nelson B, Friedman J Int J Mol Sci. 2024; 25(11).

PMID: 38892139 PMC: 11172957. DOI: 10.3390/ijms25115951.

In-depth multiomic characterization of the effects of obesity in high-fat diet-fed mice.

Li B, Chen J, Ou X, Liu X, Xu Z, Xiang X FEBS Open Bio. 2024; 14(5):771-792.

PMID: 38479983 PMC: 11073502. DOI: 10.1002/2211-5463.13788.

References

Fang X, Zuo J, Zhou J, Cai J, Chen C, Xiang E . Childhood obesity leads to adult type 2 diabetes and coronary artery diseases: A 2-sample mendelian randomization study. Medicine (Baltimore). 2019; 98(32):e16825. PMC: 6708873. DOI: 10.1097/MD.0000000000016825. View

Wolowczuk I, Hennart B, Leloire A, Bessede A, Soichot M, Taront S . Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2012; 303(2):R135-43. DOI: 10.1152/ajpregu.00373.2011. View

Oxenkrug G . Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr J Psychiatry Relat Sci. 2010; 47(1):56-63. PMC: 3021918. View

Vukovic R, Dos Santos T, Ybarra M, Atar M . Children With Metabolically Healthy Obesity: A Review. Front Endocrinol (Lausanne). 2020; 10:865. PMC: 6914809. DOI: 10.3389/fendo.2019.00865. View

Boulet M, Chevrier G, Grenier-Larouche T, Pelletier M, Nadeau M, Scarpa J . Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk. Am J Physiol Endocrinol Metab. 2015; 309(8):E736-46. DOI: 10.1152/ajpendo.00231.2015. View

Damanhoury S, Newton A, Rashid M, Hartling L, Byrne J, Ball G . Defining metabolically healthy obesity in children: a scoping review. Obes Rev. 2018; 19(11):1476-1491. DOI: 10.1111/obr.12721. View

Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T . A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008; 11(3):198-209. DOI: 10.1080/10253890701754068. View

Oxenkrug G . Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci. 2010; 1199:1-14. DOI: 10.1111/j.1749-6632.2009.05356.x. View

Theofylaktopoulou D, Midttun O, Ulvik A, Ueland P, Tell G, Vollset S . A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study. Clin Exp Immunol. 2013; 173(1):121-30. PMC: 3694542. DOI: 10.1111/cei.12092. View

10.

Raitakari O, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N . Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003; 290(17):2277-83. DOI: 10.1001/jama.290.17.2277. View

11.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

12.

Esser N, Legrand-Poels S, Piette J, Scheen A, Paquot N . Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014; 105(2):141-50. DOI: 10.1016/j.diabres.2014.04.006. View

13.

Lischka J, Schanzer A, Hojreh A, Ba-Ssalamah A, de Gier C, Valent I . Circulating microRNAs 34a, 122, and 192 are linked to obesity-associated inflammation and metabolic disease in pediatric patients. Int J Obes (Lond). 2021; 45(8):1763-1772. PMC: 8310785. DOI: 10.1038/s41366-021-00842-1. View

14.

Bluher M . Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009; 117(6):241-50. DOI: 10.1055/s-0029-1192044. View

15.

Hotamisligil G . Inflammation and metabolic disorders. Nature. 2006; 444(7121):860-7. DOI: 10.1038/nature05485. View

16.

Badawy A, Guillemin G . The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal. Int J Tryptophan Res. 2019; 12:1178646919868978. PMC: 6710706. DOI: 10.1177/1178646919868978. View

17.

Rojas I, Moyer B, Ringelberg C, Wilkins O, Pooler D, Ness D . Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia. Obesity (Silver Spring). 2021; 29(2):337-349. PMC: 10782555. DOI: 10.1002/oby.23065. View

18.

Cussotto S, Delgado I, Anesi A, Dexpert S, Aubert A, Beau C . Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation. Front Immunol. 2020; 11:557. PMC: 7174689. DOI: 10.3389/fimmu.2020.00557. View

19.

Yu E, Papandreou C, Ruiz-Canela M, Guasch-Ferre M, Clish C, Dennis C . Association of Tryptophan Metabolites with Incident Type 2 Diabetes in the PREDIMED Trial: A Case-Cohort Study. Clin Chem. 2018; 64(8):1211-1220. PMC: 6218929. DOI: 10.1373/clinchem.2018.288720. View

20.

Uppal V, Mansoor S, Furuya K . Pediatric Non-alcoholic Fatty Liver Disease. Curr Gastroenterol Rep. 2016; 18(5):24. DOI: 10.1007/s11894-016-0498-9. View